The uptake of pentazocine into brain
dc.contributor.author | Medzihradsky, Fedor | en_US |
dc.contributor.author | Ahmad, K. | en_US |
dc.date.accessioned | 2006-04-17T16:25:52Z | |
dc.date.available | 2006-04-17T16:25:52Z | |
dc.date.issued | 1971-06-15 | en_US |
dc.identifier.citation | Medzihradsky, F., Ahmad, K. (1971/06/15)."The uptake of pentazocine into brain." Life Sciences 10(12, Part 1): 711-720. <http://hdl.handle.net/2027.42/33633> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T99-4754818-99/2/8ba78055ef0564ee440ba083636c3cbd | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/33633 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5556759&dopt=citation | en_US |
dc.description.abstract | A simple procedure for the extraction from tissues and determination by gas chromatography of pentazocine was developed. The mean recovery from brain was 96%.The time- and dose-dependent uptake of pentazocine into the brain was investigated and correlated with the plasma levels of the drug. The results showed a rapid entry of pentazocine into the drug. The results showed a rapid entry of pentazocine into at 2 min and 10 min, respectively, after the i.p. administration. After the injection of a single dose, the ratio, concentration of pentazocine in plasma/concentration of pentazocine in brain was constant from 10-90 min. This ratio remained unchanged over the range of 25-100 mg/kg of administered drug. | en_US |
dc.format.extent | 323565 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | The uptake of pentazocine into brain | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Natural Resources and Environment | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbsecondlevel | Ecology and Evolutionary Biology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Biological Chemistry and Pharmacology and Upjohn Center for Clinical Pharmacology, University of Michigan, Ann Arbor, Michigan 48104, USA | en_US |
dc.contributor.affiliationum | Departments of Biological Chemistry and Pharmacology and Upjohn Center for Clinical Pharmacology, University of Michigan, Ann Arbor, Michigan 48104, USA | en_US |
dc.identifier.pmid | 5556759 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/33633/1/0000141.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0024-3205(71)90015-4 | en_US |
dc.identifier.source | Life Sciences | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.